MarketPulse
clinical trialsinvestor conferencebiomedical company

Orchestra BioMed to Present at Major Healthcare Investment Conferences

GlobeNewswire Inc.GlobeNewswire Inc.
|||1 min read
Key Takeaway

Orchestra BioMed will present at two major healthcare investor conferences in March 2026, engaging with institutional investors on strategy and clinical progress.

Orchestra BioMed to Present at Major Healthcare Investment Conferences
$MDTneutral$OBIOpositive

Orchestra BioMed Inc. (OBIO) has confirmed its participation in two prominent institutional investor conferences scheduled for March 2026. The company will present at the TD Cowen 46th Annual Health Care Conference on March 3rd and the Barclays 28th Annual Global Healthcare Conference on March 11th.

At both events, Orchestra BioMed's management team will engage in fireside chat presentations and conduct one-on-one meetings with institutional investors. These conferences provide platforms for publicly traded healthcare companies to discuss their strategic direction, clinical progress, and financial outlooks with the investment community.

The dual conference participation reflects standard practice among publicly traded life sciences firms seeking to maintain investor relations and communicate company developments to capital markets participants.

Topics

clinical trialsinvestor conferencebiomedical companyAVIM TherapyVirtue SABMedtronic partnershipFDA Breakthrough Device Designation

Source: GlobeNewswire Inc.

Back to newsPublished Feb 19

Related Coverage

GlobeNewswire Inc.

Corcept Therapeutics Faces Class Action Over FDA Rejection; Stock Crashed 50%

Corcept Therapeutics faces securities fraud lawsuit after FDA rejected relacorilant application. Stock plummeted 50.4% following December rejection. Investor deadline April 21, 2026.

CORT
GlobeNewswire Inc.

Corcept Faces Class Action Over Relacorilant Claims as Investors Allege Misleading Trial Data

Class action lawsuit filed against $COPT alleging executives misrepresented relacorilant clinical trial strength and FDA approval prospects, harming investors.

CORT
GlobeNewswire Inc.

Zymeworks to Showcase Pipeline Progress at Major Healthcare Conferences

Zymeworks will present clinical and preclinical data at two major healthcare investor conferences in April, including the Needham Virtual Healthcare Conference and Bloom Burton & Co. event.

ZYME
GlobeNewswire Inc.

Corcept Faces Securities Lawsuit Over Relacorilant Clinical Data Misrepresentation

Rosen Law Firm notifies Corcept investors about securities lawsuit alleging misrepresentation of relacorilant clinical data and concealment of FDA concerns during October 2024-December 2025.

CORT
GlobeNewswire Inc.

Plug Power Execs to Present at Roth Conference Amid Hydrogen Market Expansion

Plug Power executives to present at Roth Annual Growth Conference in March 2026, discussing company strategy and financial outlook with institutional investors.

PLUG
The Motley Fool

Boone Capital Exits 372% Biotech Winner to Chase Emerging Clinical Plays

Boone Capital liquidates entire $13.57M Cogent Biosciences stake despite 372% gain, reallocating to earlier-stage biotech plays like TYRA. Strategic rebalancing in volatile sector.

MDTTYRAIONS